Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald F Watts

Showing results (71-80 of 706) with videos related to

Pageof 71
Sort By:
Australian Prescriber|October 30, 2016
PCSK9 inhibitors - mechanisms of actionMichael M Page, Gerald F Watts
The Clinical Biochemist. Reviews|June 3, 2008
HDL revisited: new opportunities for managing dyslipoproteinaemia and cardiovascular diseaseGerald F Watts, John R Burnett
Lancet (London, England)|November 13, 2012
Into the future: diversifying lipid managementAndrew M Tonkin, Gerald F Watts
The Review of Diabetic Studies : RDS|January 1, 2014
Endothelial dysfunction in diabetes: pathogenesis, significance, and treatmentSandra J Hamilton, Gerald F Watts
Clinical Cardiology|June 17, 2014
Response to familial hypercholesterolemia: an under-recognized but significant concern in cardiology practiceDamon A Bell, Gerald F Watts
Current Opinion in Endocrinology, Diabetes, and Obesity|February 27, 2024
Addressing genetic and environmental sources of cardiometabolic diseaseGerald F Watts, Dick C Chan
The New England Journal of Medicine|February 6, 2017
Child-Parent Familial Hypercholesterolemia Screening in Primary CareAndrew C Martin, Gerald F Watts
Clinical Science (London, England : 1979)|January 10, 2008
Is adipose tissue lipolysis always an adaptive response to starvation?: implications for non-alcoholic fatty liver diseaseSeng Khee Gan, Gerald F Watts
Current Opinion in Cardiology|March 20, 2021
Contemporary perspectives on the genetics and clinical use of lipoprotein(a) in preventive cardiologyMichael M Page, Gerald F Watts
The Lancet. Diabetes & Endocrinology|April 2, 2021
A compass for navigating the perils of hypertriglyceridaemiaGerald F Watts, Natalie C Ward
Pageof 71

Showing results (71-80 of 706) with videos related to

Sort By:
Pageof 71
Australian Prescriber|October 30, 2016
PCSK9 inhibitors - mechanisms of actionMichael M Page, Gerald F Watts
The Clinical Biochemist. Reviews|June 3, 2008
HDL revisited: new opportunities for managing dyslipoproteinaemia and cardiovascular diseaseGerald F Watts, John R Burnett
Lancet (London, England)|November 13, 2012
Into the future: diversifying lipid managementAndrew M Tonkin, Gerald F Watts
The Review of Diabetic Studies : RDS|January 1, 2014
Endothelial dysfunction in diabetes: pathogenesis, significance, and treatmentSandra J Hamilton, Gerald F Watts
Clinical Cardiology|June 17, 2014
Response to familial hypercholesterolemia: an under-recognized but significant concern in cardiology practiceDamon A Bell, Gerald F Watts
Current Opinion in Endocrinology, Diabetes, and Obesity|February 27, 2024
Addressing genetic and environmental sources of cardiometabolic diseaseGerald F Watts, Dick C Chan
The New England Journal of Medicine|February 6, 2017
Child-Parent Familial Hypercholesterolemia Screening in Primary CareAndrew C Martin, Gerald F Watts
Clinical Science (London, England : 1979)|January 10, 2008
Is adipose tissue lipolysis always an adaptive response to starvation?: implications for non-alcoholic fatty liver diseaseSeng Khee Gan, Gerald F Watts
Current Opinion in Cardiology|March 20, 2021
Contemporary perspectives on the genetics and clinical use of lipoprotein(a) in preventive cardiologyMichael M Page, Gerald F Watts
The Lancet. Diabetes & Endocrinology|April 2, 2021
A compass for navigating the perils of hypertriglyceridaemiaGerald F Watts, Natalie C Ward
Pageof 71